Is second-line anti-tuberculosis drug susceptibility testing reliable?

被引：1
|
作者：
Kim, SJ [1 ]
Espinal, MA
Abe, C
Bai, GH
Boulahbals, F
Fattorinit, L
Gilpin, C
Hoffner, S
Kam, KM
Martin-Casabona, N
Rigouts, L
Vincent, V
机构：
[1] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland
[2] Japan Anti TB Assoc, Res Inst TB, Tokyo, Japan
[3] Korea Natl TB Assoc, Korean Inst TB, Seoul, South Korea
[4] Inst Pasteur Algerie Alger, Lab TB, Algiers, Algeria
[5] Inst Super San Lab Bacteriol & Med Mycol, Rome, Italy
[6] Prince Charles Hosp, Queensland Mycobacterium Reference Lab, Brisbane, Qld 4032, Australia
[7] Swedish Inst Infect Dis Control, Solna, Sweden
[8] Dept Hlth, TB Reference Lab, Hong Kong, Hong Kong, Peoples R China
[9] Ciudad Sanitaria & Univ Vall Hebron, Serv Microbiol Hosp, E-08035 Barcelona, Spain
[10] Inst Trop Med, Mycobacteriol Unit, Dept Microbiol, B-2000 Antwerp, Belgium
[11] Inst Pasteur, Ctr Natl Reference Mycobacteries, Paris, France
来源：
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2004年 / 8卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1157 / 1158
页数：2
相关论文
共 50 条
  • [21] Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa
    Maningi, Nontuthuko E.
    Malinga, Lesibana A.
    Antiabong, John F.
    Lekalakala, Ruth M.
    Mbelle, Nontombi M.
    BMC INFECTIOUS DISEASES, 2017, 17
  • [22] Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates
    Bakula, Zofia
    Napiorkowska, Agnieszka
    Kaminski, Michal
    Augustynowicz-Kopec, Ewa
    Zwolska, Zofia
    Bielecki, Jacek
    Jagielski, Tomasz
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (03) : 439 - 444
  • [23] Characterization of Genetic Mutations in Multi-Drug-Resistant Isolates of Mycobacterium tuberculosis Bacilli Conferring Resistance to a Second-Line Anti-tuberculosis Drug
    Sharma, Raj Kishor
    Kumari, Usha
    Kumari, Namrata
    Kumar, Rakesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [24] Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania
    Stellah G Mpagama
    Eric R Houpt
    Suzanne Stroup
    Happiness Kumburu
    Jean Gratz
    Gibson S Kibiki
    Scott K Heysell
    BMC Infectious Diseases, 13
  • [25] Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania
    Mpagama, Stellah G.
    Houpt, Eric R.
    Stroup, Suzanne
    Kumburu, Happiness
    Gratz, Jean
    Kibiki, Gibson S.
    Heysell, Scott K.
    BMC INFECTIOUS DISEASES, 2013, 13
  • [26] Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance
    Kam, K. M.
    Sloutsky, A.
    Yip, C. W.
    Bulled, N.
    Seung, K. J.
    Zignol, M.
    Espinal, M.
    Kim, S. J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (03) : 282 - 288
  • [27] Novel pediatric delivery systems for second-line anti-tuberculosis medications: a case study
    Furin, J.
    Brigden, G.
    Lessem, E.
    Becerra, M. C.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (09) : 1239 - 1241
  • [28] High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia
    Jugheli, L.
    Rigouts, L.
    Shamputa, I. C.
    de Rijk, W. Bram
    Portaels, F.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2008, 12 (05) : 561 - 566
  • [29] Genomic Analysis of Mycobacterium tuberculosis Strains Resistant to Second-Line Anti-Tuberculosis Drugs in Lusaka, Zambia
    Chizimu, Joseph Yamweka
    Solo, Eddie Samuneti
    Bwalya, Precious
    Kapalamula, Thoko Flav
    Mwale, Kaemba Kunkuta
    Squarre, David
    Shawa, Misheck
    Lungu, Patrick
    Barnes, David Atomanyi
    Yamba, Kaunda
    Mufune, Tiza
    Chambaro, Herman
    Kamboyi, Harvey
    Munyeme, Musso
    Hang'ombe, Bernard Mudenda
    Kapata, Nathan
    Mukonka, Victor
    Chilengi, Roma
    Thapa, Jeewan
    Nakajima, Chie
    Suzuki, Yasuhiko
    ANTIBIOTICS-BASEL, 2023, 12 (07):
  • [30] Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis
    Wu, Chunli
    Yi, Hengzhong
    Hu, Yanmei
    Luo, Danlin
    Tang, Zhigang
    Wen, Xinmin
    Zhang, Yong
    Tang, Mi
    Zhang, Lizhi
    Wu, Shu
    Chen, Mengshi
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
12345